Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2382 | 2195 | 43.0 | 87% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
36 | 32479 | HUMAN PAPILLOMAVIRUS//HPV//CERVICAL INTRAEPITHELIAL NEOPLASIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CELLULAR ONCOL | Address | 21 | 20% | 4% | 98 |
2 | EMMY NOETHER GRP VIRUS ENDOCYTOSIS | Address | 17 | 100% | 0% | 8 |
3 | PAPILLOMAVIRUS | Author keyword | 16 | 13% | 5% | 111 |
4 | HM BLIGH CANC | Address | 14 | 100% | 0% | 7 |
5 | E7 | Author keyword | 12 | 20% | 2% | 51 |
6 | HPV16 | Author keyword | 11 | 23% | 2% | 42 |
7 | HPV 16 | Author keyword | 10 | 20% | 2% | 44 |
8 | VIRUS LIKE PARTICLES | Author keyword | 9 | 12% | 3% | 73 |
9 | CAPSOMERES | Author keyword | 8 | 70% | 0% | 7 |
10 | YALE SKIN DIS | Address | 8 | 75% | 0% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PAPILLOMAVIRUS | 16 | 13% | 5% | 111 | Search PAPILLOMAVIRUS | Search PAPILLOMAVIRUS |
2 | E7 | 12 | 20% | 2% | 51 | Search E7 | Search E7 |
3 | HPV16 | 11 | 23% | 2% | 42 | Search HPV16 | Search HPV16 |
4 | HPV 16 | 10 | 20% | 2% | 44 | Search HPV+16 | Search HPV+16 |
5 | VIRUS LIKE PARTICLES | 9 | 12% | 3% | 73 | Search VIRUS+LIKE+PARTICLES | Search VIRUS+LIKE+PARTICLES |
6 | CAPSOMERES | 8 | 70% | 0% | 7 | Search CAPSOMERES | Search CAPSOMERES |
7 | RESIDUAL TUMOUR DISEASE | 8 | 100% | 0% | 5 | Search RESIDUAL+TUMOUR+DISEASE | Search RESIDUAL+TUMOUR+DISEASE |
8 | PROPHYLACTIC VACCINE | 6 | 35% | 1% | 15 | Search PROPHYLACTIC+VACCINE | Search PROPHYLACTIC+VACCINE |
9 | HPV ANTIBODIES | 6 | 100% | 0% | 4 | Search HPV+ANTIBODIES | Search HPV+ANTIBODIES |
10 | L1 MAJOR CAPSID PROTEIN | 6 | 100% | 0% | 4 | Search L1+MAJOR+CAPSID+PROTEIN | Search L1+MAJOR+CAPSID+PROTEIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VIRUS LIKE PARTICLES | 217 | 28% | 30% | 664 |
2 | L1 PROTEIN | 216 | 68% | 9% | 190 |
3 | COTTONTAIL RABBIT PAPILLOMAVIRUS | 165 | 66% | 7% | 154 |
4 | MINOR CAPSID PROTEIN | 99 | 57% | 5% | 117 |
5 | PSEUDOVIRIONS | 75 | 83% | 2% | 43 |
6 | L2 CAPSID PROTEINS | 56 | 100% | 1% | 19 |
7 | ANOGENITAL INTRAEPITHELIAL NEOPLASIA | 41 | 100% | 1% | 15 |
8 | TYPE 16 L1 | 37 | 81% | 1% | 22 |
9 | E7 PROTEINS | 37 | 59% | 2% | 41 |
10 | HUMAN PAPILLOMAVIRUS TYPE 16 | 37 | 11% | 14% | 312 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Recent progress in vaccination against human papillomavirus-mediated cervical cancer | 2015 | 2 | 139 | 49% |
Immunotherapy for Cervical Cancer Research Status and Clinical Potential | 2010 | 37 | 170 | 74% |
Mechanisms of cell entry by human papillomaviruses: an overview | 2010 | 34 | 64 | 78% |
How will HPV vaccines affect cervical cancer? | 2006 | 136 | 102 | 58% |
Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus | 2009 | 48 | 78 | 88% |
Prevention of cervical cancer through papillomavirus vaccination | 2004 | 188 | 76 | 63% |
The Evolving Field of Human Papillomavirus Receptor Research: a Review of Binding and Entry | 2013 | 20 | 102 | 61% |
Therapeutic human papillomavirus vaccines: current clinical trials and future directions | 2008 | 53 | 134 | 75% |
Prophylactic human papillomavirus vaccines | 2006 | 155 | 35 | 40% |
Epithelial Cell Responses to Infection with Human Papillomavirus | 2012 | 39 | 76 | 39% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CELLULAR ONCOL | 21 | 20% | 4.5% | 98 |
2 | EMMY NOETHER GRP VIRUS ENDOCYTOSIS | 17 | 100% | 0.4% | 8 |
3 | HM BLIGH CANC | 14 | 100% | 0.3% | 7 |
4 | YALE SKIN DIS | 8 | 75% | 0.3% | 6 |
5 | MOL VIROL MED BIOCHEM | 8 | 100% | 0.2% | 5 |
6 | JAKE GITTLEN CANC | 7 | 25% | 1.1% | 25 |
7 | IMUL | 6 | 80% | 0.2% | 4 |
8 | TUMOR VIRUS EPIDEMIOL | 4 | 67% | 0.2% | 4 |
9 | ATV F035 | 4 | 75% | 0.1% | 3 |
10 | VIROL BIOL CELLULAIRE IMMUNOL | 4 | 75% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000121943 | E6//PAPILLOMAVIRUS//E7 |
2 | 0.0000112043 | HPV VACCINE//HPV VACCINATION//HUMAN PAPILLOMAVIRUS VACCINE |
3 | 0.0000106496 | POLYOMAVIRUS VP1//SV40 VECTORS//SECT VIROL ONCOL |
4 | 0.0000098949 | HUMAN PAPILLOMAVIRUS//HPV//CERVICAL CANCER |
5 | 0.0000082456 | EPIDERMODYSPLASIA VERRUCIFORMIS//BETAPAPILLOMAVIRUS//BOWENOID IN SITU CARCINOMA |
6 | 0.0000073795 | CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS//HIV IN WOMEN//CERVICAL DYSPLASIA |
7 | 0.0000073473 | CONDYLOMATA ACUMINATA//GENITAL WARTS//PENISCOPY |
8 | 0.0000063245 | INTERDISCIPLINARY STUDIES SECT//BIOL SCI TUNIS//BLOOD TRANSFUS 1 |
9 | 0.0000059353 | RECURRENT RESPIRATORY PAPILLOMATOSIS//LARYNGEAL PAPILLOMATOSIS//LARYNGEAL PAPILLOMA |
10 | 0.0000056717 | DNA VACCINE//DNA VACCINES//DNA IMMUNIZATION |